xB3-002

N/A

Report date: 2025/03/20 14:37:31

Base Information

Drug NamexB3-002
Drug Alias NameMTfp-miRNA
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioasis Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioasis Technologies Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A